Donald Notman

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Bedford, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Todd Anderman, Attorney-in-Fact for Donald Notman
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Donald Notman

Form 4 holding Chief Operating Officer

OCULAR THERAPEUTIX, INC

Security class
Stock Option (Right to Buy)
Shares / value
240,932
Estimated value
Report date
02 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Donald Notman

4 OCUL

OCULAR THERAPEUTIX, INC

Report period
02 Sep 2025
Transactions
1
Transaction value
-$13,250
Accepted by SEC
04 Sep 2025, 16:50
Role
Chief Financial Officer and Chief Operating Officer. Exhibit Index Exhibit 24 - Power of Attorney
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .